Does PEMBROLIZUMAB Cause Disease progression? 769 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 769 reports of Disease progression have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.9% of all adverse event reports for PEMBROLIZUMAB.
769
Reports of Disease progression with PEMBROLIZUMAB
0.9%
of all PEMBROLIZUMAB reports
241
Deaths
148
Hospitalizations
How Dangerous Is Disease progression From PEMBROLIZUMAB?
Of the 769 reports, 241 (31.3%) resulted in death, 148 (19.2%) required hospitalization, and 24 (3.1%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which PEMBROLIZUMAB Alternatives Have Lower Disease progression Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G